Nurix Therapeutics, Inc. (NRIX)
19.30
+0.67
(+3.60%)
USD |
NASDAQ |
Jan 09, 16:00
19.30
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics Total Liabilities (Quarterly): 150.22M for Aug. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| GT Biopharma, Inc. | 1.321M |
| Incyte Corp. | 1.679B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Madrigal Pharmaceuticals, Inc. | 736.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 522.47M |
| Shareholders Equity (Quarterly) | 372.25M |
| Debt to Equity Ratio | 0.1517 |
| Current Ratio | 5.350 |
| Net Debt Paydown Yield | -0.77% |